P/ 310-827-7707 | F/ 310-574-4002 | MAIL@PROSTATEONCOLOGY.COM
When metastases are extensive at diagnosis, standard radiation is no longer feasible because radiation to multiple areas of the bone is too damaging to the bone marrow where blood is formed and the immune system resides. Testosterone inactivating pharmaceuticals (TIP) are the mainstay for treatment in men with bone metastases. There is also some evidence that adding Taxotere chemotherapy to TIP improves cancer control rates. Bone supportive agent such as Zometa or Xgeva should also be administered. Injectable radiation with Samarium or Strontium can be effective for controlling widespread pain when other treatments like TIP or Taxotere don’t seem to be working. However, like standard radiation, injectable radiation can have a long lasting suppressive effect on the bone marrow.
Listen: https://soundcloud.com/prostate-oncology/dont-reject-radiation “Historically, metastatic cancer has such a bleak outlook that people address this problem of progressive cancer sometimes with denial. The thinking is ‘well, doctors can’t do much anyway.’ …